CTMC
Houston, TX
National Center
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
63.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: CTMC
- Signal Score
- 63.0/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Houston, TX
- Modalities
- CAR-T, Cell Therapy, Gene Editing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About CTMC
MD Anderson-affiliated CGT manufacturing center.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
68.0
Parent company: MD Anderson Cancer Center
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: MD Anderson Cancer Center
Financial assessment: 68.0/100
Capacity
58.0
1 manufacturing site: Houston, TX
Modalities: CAR-T, Cell Therapy, Gene Editing
Capacity assessment: 58.0/100
Sites: Houston, TX
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals1 articles (not scored)
1 manufacturing site: Houston, TX
Modalities: CAR-T, Cell Therapy, Gene Editing
Capacity assessment: 58.0/100
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
CTMC Reaches Pivotal-Stage TIL Manufacturing Milestone and Expands Proprietary TIL Platform - Business Wire
CTMC Reaches Pivotal-Stage TIL Manufacturing Milestone and Expands Proprietary TIL Platform Business Wire
Frequently Asked Questions About CTMC
What is CTMC's CDMO Signal Score?
CTMC has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating CTMC for a manufacturing program?
Use the free AI matchmaker to compare CTMC against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 79.3
CAR-T, Cell Therapy, iPSC, Gene Editing
GenScript
Piscataway, NJ / Nanjing, China
Signal Score: 64.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
C3i Center
Houston, TX
Signal Score: 59.0
Cell Therapy, Gene Editing
Compare CTMC with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.